Drug Therapy During Continuous Arteriovenous Hemofiltration
Since the first description of continuous arteriovenous hemofiltration as a method of emergency fluid removal (Kramer et al. 1977), this measure has gained wide acceptance predominantly as a supportive treatment of acute renal failure in critically ill patients. It has been shown that the machinefree hemofiltration allows liberal parenteral nutrition without the risk of fluid overload. In addition it has some capacity to remove uremic toxins. The method can be applied without sophisticated apparative equipment and without trained dialysis personal being familiar with the problems of extracorporal circulation.
KeywordsAcute Renal Failure Drug Clearance Total Clearance Drug Elimination Ultrafiltration Rate
Unable to display preview. Download preview PDF.
- Bozkurt F., Hörl W.H., 1987, Bedeutung der kontinuierlichen arteriovenösen Hämofiltration (CAVH) und arteriovenösen Hämodiafiltration (AV-HDF) in der Intensivtherapie, Intensivmed., 24: 248.Google Scholar
- Kates R.E., Leier C.V., 1987, Dobutamine pharmacokinetics in severe heart failure, Clin. Pharmacol. Ther., 24: 537.Google Scholar
- Keller E., Fecht H., Böhler J., Schollmeyer P., 1989, Single dose kinetics of Imipenem Cilastatin during continuous arteriovenous hemofiltration in intensive care patients, Nephr. Dial. and Transplant., (submitted).Google Scholar
- Lau A.H., Kronfol N.O., John E., 1987, Increased vancomycin elimination with continuous hemofiltration, Trans. Am. Soc. Artif. Intern. Organs., 33: 772.Google Scholar
- Reeves D.S., Chapman S.T., Davies A.J., Ferber V.F., Rogers J.D., 1983, Human pharmacokinetics of N-Formimidoyl thienamycin alone and in combination with a dehydropeptidase inhibitor (MK 791 ) and probenecid. In: Spitzy KH, Karrer K eds., Proceedings of the thirteens International congress of Chemotherapy. Vienna, Austria, Vol 3, part 95: 30.Google Scholar